Arena Pharmaceuticals Inc. (ARNA)

58.41
1.18 2.06
NASDAQ : Health Technology
Prev Close 57.23
Open 57.05
Day Low/High 56.45 / 58.81
52 Wk Low/High 31.97 / 59.13
Volume 535.60K
Avg Volume 520.30K
Exchange NASDAQ
Shares Outstanding 49.57M
Market Cap 2.74B
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
The Next Big Thing in Biotech: Vivus

The Next Big Thing in Biotech: Vivus

Adam Feuerstein, senior columnist for TheStreet, says Vivus is the next big thing in biotech.

3 Stocks I Saw on TV, July 12

3 Stocks I Saw on TV, July 12

Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Tibco Software, Arena Pharma, and Church & Dwight.

JMP Healthcare Conf.

In the Arena of Common Sense

If a stock is up 500% in a straight line, you take something off the table.

Fitz Bits: MasterCard Keeps Working

Fitz Bits: MasterCard Keeps Working

Despite some worrisome action, the uptrend is still intact. Keep an eye on this particular level.

The Next Big Thing in Biotech: Arena

The Next Big Thing in Biotech: Arena

Senior columnist Adam Feuerstein says Arena Pharmaceuticals is the next big thing in biotech.

Long Shot: SWKH Is Betting on Biotechs

The company wants to create a specialty finance business that will provide capital to help fund testing for drugs or devices.

Don't Chase ARNA

Don't Chase ARNA

The stock is way too extended to consider buying at current levels.

Arena Pharmaceuticals downgraded at BMO

One of the Best Trends I've Ever Seen

In this trend I look for momentum, velocity, acceleration and speed, especially with options.

The Next Big Thing in Biotech: Arena

The Next Big Thing in Biotech: Arena

Adam Feuerstein, senior columnist for TheStreet, says Arena Pharmaceuticals is the next big thing in biotech.

Stocks Under $10: #SU10chat Recap

Stocks Under $10: #SU10chat Recap

Portfolio Manager David Peltier recaps the highlights of his monthly live Twitter chat.

Stocks Under $10: Why I'm a Buyer

Stocks Under $10: Why I'm a Buyer

Portfolio manager David Peltier discusses where he's putting money to work during the market correction.

Fitz Bits: A Low-Risk Play on JPMorgan

Fitz Bits: A Low-Risk Play on JPMorgan

While the bank's loss is embarrassing, this could also be a buying opportunity

Cramer: Arena Is a Lottery Ticket That Paid Off

Cramer: Arena Is a Lottery Ticket That Paid Off

Jim Cramer explains it's important for smaller companies to have the opportunity to come up with solutions to dreaded diseases like obesity.

Stocks Under $10: Answering Viewer Questions

Stocks Under $10: Answering Viewer Questions

Portfolio Manager David Peltier @davidspeltier recaps his latest live #SU10chat on Twitter.